세계의 동물 모델 시장 규모 조사 및 예측 : 동물 유형별, 기술별, 용도별 및 지역별 분석(2023-2030년)

Global Animal Model Market is anticipated to grow with a growth rate of more than 8.6% over the forecast period 2023-2030. An animal model refers to a living organism, typically an animal, used in scientific research to simulate and study biological and pathological processes, as well as to understand and investigate various aspects of human health and disease. Animal models serve as experimental systems that mimic certain aspects of human physiology, anatomy, genetics, and behavior, allowing scientists to observe and manipulate these systems in controlled laboratory settings. Animal models are employed across various disciplines, including biomedical research, drug development, genetics, toxicology, and behavioral studies, to gain insights into fundamental biological processes, test hypotheses, evaluate treatments, and advance scientific knowledge. The Animal Model Market is growing because of factors such as increasing preclinical trials, increasing adoption of CRISPR technology and growing investments in R&D of pharmaceutical industry.

According to Statista, globally, the R&D spending in the pharmaceutical industry reached approximately USD 238 billion in 2021. The growing rate of preclinical trials is also helping in driving the market growth. According to the World Health Organization (WHO) report in February 2022, there were 47,689 registered preclinical trial studies conducted in 2021. This significant increase in the number of preclinical studies indicates a growing demand for animal models in research. Moreover, advancements in genetic engineering and genome editing techniques may create lucrative opportunities for the market. However, high research cost and growing criticism on animal testing by several organizations stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Animal Model Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share owing to factors such as the presence of key industry players, increasing biomedical research in the United States, and the growing preclinical activities conducted by clinical research organizations (CROs) and pharmaceutical companies in the region. However, Asia Pacific is expected to grow significantly during the forecast period, owing to increase in the government initiatives and investments in drug research utilizing animal models, the growing significance of mouse clinical trials (MCTs) for improved outcome projections, ongoing innovations in animal models, the availability of advanced healthcare systems, and a substantial surge in demand for advanced healthcare facilities.

Major market player included in this report are:

• Biocytogen Pharmaceuticals Co. Ltd
• Labcorp UK Limited (Envigo Rms Inc.)
• Hera Testing Laboratories
• Charles River Laboratories International Inc.
• The Jackson Laboratory
• Harbour BioMed Co. Ltd
• PerkinElmer Inc. (Horizon Discovery Group PLC)
• Janvier Labs
• Trans Genic Inc.
• Taconic Biosciences Inc.

Recent Developments in the Market:

• In June 2023, Charles River Laboratories International, Inc. and Curigin, a Korean biotechnology company specializing in the development of innovative oncolytic ribonucleic acid interference (RNAi) gene therapies, announced a collaborative partnership. The collaboration aims to focus on adenoviral vector production, a critical component in the development of gene therapies.
• In May 2023, Biocytogen Pharmaceuticals Co., Ltd. has announced their expansion in San Francisco, California, USA. The newly established space will help in facilitating the global expansion of Biocytogen's businesses.
• In March 2023, Biocytogen Pharmaceuticals Co., Ltd. and Janssen Biotech, Inc., a subsidiary of Johnson & Johnson's Janssen Pharmaceutical Companies, have entered into a non-exclusive license agreement. The agreement was facilitated by Johnson & Johnson Innovation LLC.

Global Animal Model Market Report Scope:

• Historical Data: 2020 - 2021
• Base Year for Estimation: 2022
• Forecast period: 2023-2030
• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: Animal, Technology, Application, Region
• Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Animal Type:

• Mice
• Birds
• Fish
• Cattle
• Other Animal Types

By Technology:

• CRISPR
• Embryonic Stem Cell Injection
• Nuclear Transfer
• Other Technologies

By Application:

• Oncology
• Cardiovascular
• Neurology
• Other Applications

By Region:

• North America
• U.S.
• Canada

• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

• Latin America
• Brazil
• Mexico

• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1. Animal Model Market, by region, 2020-2030 (USD Billion)
  • 1.2.2. Animal Model Market, by Animal Type, 2020-2030 (USD Billion)
  • 1.2.3. Animal Model Market, by Technology, 2020-2030 (USD Billion)
  • 1.2.4. Animal Model Market, by Application, 2020-2030 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Animal Model Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Animal Model Market Dynamics

• 3.1. Animal Model Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing number of preclinical trials
    • 3.1.1.2. Increasing adoption of CRISPR technology
    • 3.1.1.3. Growing investments in pharmaceutical R&D
  • 3.1.2. Market Challenges
    • 3.1.2.1. High research cost
    • 3.1.2.2. Growing criticism on animal testing by organizations
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Advancements in genetic engineering

Chapter 4. Global Animal Model Market:Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economic
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Animal Model Market, by Animal Type

• 5.1. Market Snapshot
• 5.2. Global Animal Model Market by Animal Type, Performance - Potential Analysis
• 5.3. Global Animal Model Market Estimates & Forecasts by Animal Type 2020-2030 (USD Billion)
• 5.4. Animal Model Market, Sub Segment Analysis
  • 5.4.1. Mice
  • 5.4.2. Birds
  • 5.4.3. Fish
  • 5.4.4. Cattle
  • 5.4.5. Other Animal Types

Chapter 6. Global Animal Model Market, by Technology

• 6.1. Market Snapshot
• 6.2. Global Animal Model Market by Technology, Performance - Potential Analysis
• 6.3. Global Animal Model Market Estimates & Forecasts by Technology 2020-2030 (USD Billion)
• 6.4. Animal Model Market, Sub Segment Analysis
  • 6.4.1. CRISPR
  • 6.4.2. Embryonic Stem Cell Injection
  • 6.4.3. Nuclear Transfer
  • 6.4.4. Other Technologies

Chapter 7. Global Animal Model Market, by Application

• 7.1. Market Snapshot
• 7.2. Global Animal Model Market by Application, Performance - Potential Analysis
• 7.3. Global Animal Model Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
• 7.4. Animal Model Market, Sub Segment Analysis
  • 7.4.1. Oncology
  • 7.4.2. Cardiovascular
  • 7.4.3. Neurology
  • 7.4.4. Other Applications

Chapter 8. Global Animal Model Market, Regional Analysis

• 8.1. Top Leading Countries
• 8.2. Top Emerging Countries
• 8.3. Animal Model Market, Regional Market Snapshot
• 8.4. North America Animal Model Market
  • 8.4.1. U.S. Animal Model Market
    • 8.4.1.1. Animal Type breakdown estimates & forecasts, 2020-2030
    • 8.4.1.2. Technology breakdown estimates & forecasts, 2020-2030
    • 8.4.1.3. Application breakdown estimates & forecasts, 2020-2030
  • 8.4.2. Canada Animal Model Market
• 8.5. Europe Animal Model Market Snapshot
  • 8.5.1. U.K. Animal Model Market
  • 8.5.2. Germany Animal Model Market
  • 8.5.3. France Animal Model Market
  • 8.5.4. Spain Animal Model Market
  • 8.5.5. Italy Animal Model Market
  • 8.5.6. Rest of Europe Animal Model Market
• 8.6. Asia-Pacific Animal Model Market Snapshot
  • 8.6.1. China Animal Model Market
  • 8.6.2. India Animal Model Market
  • 8.6.3. Japan Animal Model Market
  • 8.6.4. Australia Animal Model Market
  • 8.6.5. South Korea Animal Model Market
  • 8.6.6. Rest of Asia Pacific Animal Model Market
• 8.7. Latin America Animal Model Market Snapshot
  • 8.7.1. Brazil Animal Model Market
  • 8.7.2. Mexico Animal Model Market
• 8.8. Middle East & Africa Animal Model Market
  • 8.8.1. Saudi Arabia Animal Model Market
  • 8.8.2. South Africa Animal Model Market
  • 8.8.3. Rest of Middle East & Africa Animal Model Market

Chapter 9. Competitive Intelligence

• 9.1. Key Company SWOT Analysis
  • 9.1.1. Company 1
  • 9.1.2. Company 2
  • 9.1.3. Company 3
• 9.2. Top Market Strategies
• 9.3. Company Profiles
  • 9.3.1. Biocytogen Pharmaceuticals Co. Ltd
    • 9.3.1.1. Key Information
    • 9.3.1.2. Overview
    • 9.3.1.3. Financial (Subject to Data Availability)
    • 9.3.1.4. Product Summary
    • 9.3.1.5. Recent Developments
  • 9.3.2. Labcorp UK Limited (Envigo Rms Inc.)
  • 9.3.3. Hera Testing Laboratories
  • 9.3.4. Charles River Laboratories International Inc.
  • 9.3.5. The Jackson Laboratory
  • 9.3.6. Harbour BioMed Co. Ltd
  • 9.3.7. PerkinElmer Inc. (Horizon Discovery Group PLC)
  • 9.3.8. Janvier Labs
  • 9.3.9. Trans Genic Inc.
  • 9.3.10. Taconic Biosciences Inc.

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption